Susan M. Catalano
Net worth: 177 $ as of 30/04/2024
Profile
Susan M.
Catalano is the founder of Cognition Therapeutics, Inc. which was founded in 2007.
She held the title of Director & Chief Scientific Officer from 2011 to 2022.
Dr. Catalano's former jobs include Director-Discovery Biology at Acumen Pharmaceuticals, Inc. and Senior Scientist at Rigel Pharmaceuticals, Inc. She earned a doctorate degree from the University of California, Irvine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
WEWORK INC. CLASS A
0.00% | 20/03/2023 | 1,472 ( 0.00% ) | 177 $ | 30/04/2024 |
Former positions of Susan M. Catalano
| Companies | Position | End |
|---|---|---|
| COGNITION THERAPEUTICS, INC. | Founder | 01/02/2022 |
| RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| ACUMEN PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Susan M. Catalano
| University of California, Irvine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| COGNITION THERAPEUTICS, INC. | Health Technology |
| ACUMEN PHARMACEUTICALS, INC. | Health Technology |
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
- Stock Market
- Insiders
- Susan M. Catalano
